Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9900-0.0300 (-1.49%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
4,307
3,634
6,973
8,249
Total cash
4,307
3,634
6,973
8,249
Net receivables
1,496
1,286
1,641
1,364
Inventory
2,470
3,153
4,462
5,304
Other current assets
132
188
207
237
Total current assets
8,405
8,261
13,634
15,154
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,921
2,023
1,515
2,175
Accumulated depreciation
-962
-923
-829
-843
Net property, plant and equipment
1,959
1,100
686
1,332
Goodwill
759
759
759
759
Intangible assets
652
825
1,001
1,176
Other long-term assets
86
54
1,570
89
Total non-current assets
3,456
2,738
4,016
3,356
Total assets
11,861
10,999
17,650
18,510
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
71
248
229
Accounts payable
873
740
1,334
423
Accrued liabilities
758
268
397
341
Other current liabilities
-
-
51
-
Total current liabilities
2,113
1,412
2,390
1,325
Non-current liabilities
Long-term debt
-
1
99
853
Total non-current liabilities
1,390
706
511
1,612
Total liabilities
3,503
2,118
2,901
2,937
Stockholders' equity
Common stock
10
10
10
10
Retained earnings
-144,406
-142,831
-135,725
-131,858
Accumulated other comprehensive income
-
0
64
74
Total stockholders' equity
8,358
5,592
11,695
12,522
Total liabilities and stockholders' equity
11,861
10,999
17,650
18,510